Raynier Devillier

3.3k citations

84 papers · 1.5k indexed · h-index 23

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 62
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 10
Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 10
Genetics top 5%
Immunology top 5%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 10
Oncology top 10%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 19
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 10

Co-authors: Didier Blaise Daniel Birnbaum Julien Mozziconacci Mandy Brecqueville Anne Murati Véronique Gelsi‐Boyer Norbert Vey Christian Chabannon
Cited by: Hematology Transplantation Genetics
Journals: Blood (21 papers)Bone Marrow Transplantation (18 papers)Biology of Blood and Marrow Transplantation (13 papers)
Partner nations: France Italy United States

In The Last Decade

Raynier Devillier

76 papers receiving 1.5k citations

Peers

Countries citing papers authored by Raynier Devillier

Since Specialization

Citations

This map shows the geographic impact of Raynier Devillier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raynier Devillier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raynier Devillier more than expected).

Fields of papers citing papers by Raynier Devillier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raynier Devillier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raynier Devillier. The network helps show where Raynier Devillier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raynier Devillier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raynier Devillier Line = papers co-authored together Raynier Devillier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire Bone Marrow Transplantation ·Koroleva La,Sylvie Chevret,Xavier Poiré,Magalie Joris,Patrice Chevallier,Jean Bourhis,Édouard Forcade,Sylvain Chantepie,David Beauvais,Nicole Raus,Jacques‐Olivier Bay,Michaël Loschi,Raynier Devillier,Rémy Duléry,Patrice Céballos,Marie Thérèse Rubio,Sophie Servais,Stéphanie Nguyen,Marie Robin	2024	0
2	IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation HemaSphere ·Cristina Bedoya,Shao Hua Li,Édouard Forcade,Marie Robin,Marie‐Thérèse Rubio,杨吉忠,Micha Srour,Natacha Maillard,Raynier Devillier,Anne Huynh,Jean Bourhis,Célestine Simand,Sylvain Chantepie,Marina Lahowin,Marie Kroemer,Éric Deconinck,Ana Berceanu	2024	0
3	GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation Bone Marrow Transplantation ·Chauvel,Sabine Fürst,Boris Calmels,Thomas Pagliardini,Samia Harbi,Vidal Sáez Sáez,Kathrin Audehm,Claude Lemarié,宗弘目片,Giles Goatly,Faézeh Legrand,Zhou Liang,Angéla Granata,Pierre Jean Weiller,Christian Chabannon,Jean‐Marc Schiano de Colella,Norbert Vey,Didier Blaise,Raynier Devillier	2023	2
4	Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis Frontiers in Medicine ·Xiaonong Wang,M. Jobard,Lining Wang,Ming Wan,Xuan Wang,Raynier Devillier,Bekee C.L,Didier Blaise,Jiong Hu	2023	5
5	Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity Journal for ImmunoTherapy of Cancer ·P Bernard,Rebecca B. Delconte,Sonia Pastor,Deborah Powell,Melissa MacKay,Armelle Goubard,Emmanuelle Josselin,Rémy Castellano,David Newsum,Xiaowen Dai,Raynier Devillier,Daniel Olive,Els Verhoeyen,Éric Vivier,Nicholas D. Huntington,Jacques A. Nunès,Geoffrey Guittard	2022	48
6	Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer Clinical Cancer Research ·Philippe Rochigneux,Aaron Lisberg,Alejandro J. Garcia,Samuel Granjeaud,Anne Madroszyk,F. A. Sanchez,Anthony Gonçalvès,Raynier Devillier,Pauline Maby,D. S Rabinovich,Laurent Gorvel,Brice Chanez,Jaklin Gukasyan,James Carroll,Jonathan W. Goldman,Anne-Sophie Chrétien,Daniel Olive,Edward B. Garon	2022	20
7	Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore) British Journal of Haematology ·Matthew F. Gilbert,T. Zh Tozhibaev,Raynier Devillier,Lionel Galicier,宗弘目片,Gilles Piana,Flora Poizat,Marion Faucher,Norbert Vey,Frédéric Gonzalez,Fabiana De Jesus Benetti,Laurent Chow‐Chine,Antoine Sannini,Djamel Mokart,Colombe Saillard,Magali Bisbal	2022	2
8	In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study Blood Advances ·Raynier Devillier,Édouard Forcade,Alice Garnier,U. Christoph,Sylvain Thépot,Gaëlle Guillerm,Patrice Céballos,Yosr Hicheri,Pierre‐Yves Dumas,Pierre Péterlin,Mathilde Hunault,Marie C. Béné,Anne Bouvier,Patrice Chevallier,Didier Blaise,Norbert Vey,Arnaud Pigneux,Christian Récher,Anne Huynh	2021	17
9	Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes Bone Marrow Transplantation ·Xuan Wang,Raynier Devillier,Ming Wan,Justine Decroocq,太佐久間,Sabine Fürst,Lining Wang,Norbert Vey,Xing Fan,Didier Blaise,Jiong Hu	2018	9
10	Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients Bone Marrow Transplantation ·Thomas Pagliardini,Samia Harbi,Sabine Fürst,Luca Castagna,Faézeh Legrand,Catherine Faucher,Angéla Granata,Pierre‐Jean Weiller,Boris Calmels,Claude Lemarié,Christian Chabannon,Réda Bouabdallah,Djamel Mokart,Norbert Vey,Didier Blaise,Raynier Devillier	2018	19
11	Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis Biology of Blood and Marrow Transplantation ·Luca Castagna,Alberto Mussetti,Raynier Devillier,Alida Dominietto,Magda Marcatti,Giuseppe Milone,Francesco Maura,Chiara De Philippis,Benedetto Bruno,Sabine Fürst,Didier Blaise,Paolo Corradini,Vittorio Montefusco	2017	23
12	T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors Biology of Blood and Marrow Transplantation ·Jacopo Mariotti,Raynier Devillier,Stéfania Bramanti,Barbara Sarina,Sabine Fürst,Angéla Granata,Catherine Faucher,Samia Harbi,Lucio Morabito,Christian Chabannon,Carmelo Carlo‐Stella,Réda Bouabdallah,Armando Santoro,Didier Blaise,Luca Castagna	2017	32
13	Cost-Effectiveness Analysis of Haploidentical Vs Matched Unrelated Allogeneic Hematopoietic Stem Cells Transplantation in Patients Older Than 55 Years Value in Health ·荻野昌利,Julius Alsberg,Catherine Faucher,Achile J. M. de Man,Claude Lemarié,Christian Chabannon,Sabine Fürst,Raynier Devillier,S. Dingfelder,Didier Blaise,Cheng Zi-bin	2017	3
14	Killer Cell Immunoglobulin-Like Receptor–Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell–Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide Biology of Blood and Marrow Transplantation ·Huiguang Zheng,Stéfania Bramanti,Samia Harbi,Sabine Fürst,Faézeh Legrand,Catherine Faucher,Yin Zuo-ru,Boris Calmels,Claude Lemarié,Christophe Picard,Christian Chabannon,Pierre‐Jean Weiller,Luca Castagna,Didier Blaise,Raynier Devillier	2017	39
15	T-cell-replete haploidentical transplantation in acute myeloid leukemia Experimental Hematology ·Luca Castagna,Raynier Devillier,Norbert Vey,Didier Blaise	2017	6
16	Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation Bone Marrow Transplantation ·Luca Castagna,Barbara Sarina,Roberto Crocchiolo,Stéfania Bramanti,Sabine Fürst,Raynier Devillier,Diane Coso,Réda Bouabdallah,Djamel Mokart,Lucio Morabito,聡安蒜,Laura Giordano,嵩山岸,P.J. Weiller,Carmelo Carlo‐Stella,Armando Santoro,Christian Chabannon,Didier Blaise	2016	4
17	T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes Bone Marrow Transplantation ·Raynier Devillier,Stéfania Bramanti,Sabine Fürst,Barbara Sarina,Jean El Cheikh,Roberto Crocchiolo,Angéla Granata,Christian Chabannon,Lucio Morabito,聡安蒜,C. Faucher,Armando Santoro,M.S. Anderson,Norbert Vey,Carmelo Carlo‐Stella,Luca Castagna,Didier Blaise	2015	18
18	Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation Biology of Blood and Marrow Transplantation ·Raynier Devillier,聡安蒜,Sabine Fürst,Roberto Crocchiolo,Jean El Cheikh,Luca Castagna,Anne Etienne,Boris Calmels,Claude Lemarié,Thomas Prébet,Angéla Granata,Aude Charbonnier,Jérôme Rey,Christian Chabannon,Catherine Faucher,Norbert Vey,Didier Blaise	2014	8
19	Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases Journal of Hematology & Oncology ·Véronique Gelsi‐Boyer,Mandy Brecqueville,Raynier Devillier,Anne Murati,Julien Mozziconacci,Daniel Birnbaum	2012	188
20	Improved outcome of patients with low‐ and intermediate‐risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine Cancer ·Thomas Prébet,Anne Etienne,Raynier Devillier,Patricia Penaloza,Aude Charbonnier,Evelyne D’Incan,Benjamin Esterni,Christine Arnoulet,Didier Blaise,Norbert Vey	2010	14

About Raynier Devillier

Raynier Devillier is a scholar working on Hematology, Transplantation and Immunology, having authored 84 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (62 papers), Acute Myeloid Leukemia Research (35 papers), Immune Cell Function and Interaction (21 papers), Acute Lymphoblastic Leukemia research (19 papers), Renal Transplantation Outcomes and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (10 papers), T-cell and B-cell Immunology (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Hematology (1.1k citations), Transplantation (82 citations) and Genetics (278 citations). Raynier Devillier has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Didier Blaise, Daniel Birnbaum, Julien Mozziconacci, Mandy Brecqueville, Anne Murati, Véronique Gelsi‐Boyer, Norbert Vey, Christian Chabannon, Luca Castagna and Angéla Granata. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact